| Leptin and obesity: role and clinical implication M Obradovic, E Sudar-Milovanovic, S Soskic, M Essack, S Arya, ... Frontiers in endocrinology 12, 585887, 2021 | 896 | 2021 |
| Apoptosis and acute brain ischemia in ischemic stroke D Radak, N Katsiki, I Resanovic, A Jovanovic, E Sudar-Milovanovic, ... Current vascular pharmacology 15 (2), 115-122, 2017 | 465 | 2017 |
| Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases A Trpkovic, I Resanovic, J Stanimirovic, D Radak, SA Mousa, ... Critical reviews in clinical laboratory sciences 52 (2), 70-85, 2015 | 404 | 2015 |
| Link between metabolic syndrome and insulin resistance Z Gluvic, B Zaric, I Resanovic, M Obradovic, A Mitrovic, D Radak, ... Current vascular pharmacology 15 (1), 30-39, 2017 | 281 | 2017 |
| Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway L Vucicevic, M Misirkic, J Kristina, U Vilimanovich, E Sudar, E Isenovic, ... Autophagy 7 (1), 40-50, 2011 | 281 | 2011 |
| Homocysteine and hyperhomocysteinaemia BL Zaric, M Obradovic, V Bajic, MA Haidara, M Jovanovic, ER Isenovic Current medicinal chemistry 26 (16), 2948-2961, 2019 | 260 | 2019 |
| Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure SS Soskić, BD Dobutović, EM Sudar, MM Obradović, DM Nikolić, ... The open cardiovascular medicine journal 5, 153, 2011 | 221 | 2011 |
| Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches D Nikolic, N Katsiki, G Montalto, ER Isenovic, DP Mikhailidis, M Rizzo Nutrients 5 (3), 928-948, 2013 | 207 | 2013 |
| Interleukin-1β regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes MC LaPointe, E Isenović Hypertension 33 (1), 276-282, 1999 | 187 | 1999 |
| Glutathione “redox homeostasis” and its relation to cardiovascular disease VP Bajic, C Van Neste, M Obradovic, S Zafirovic, D Radak, VB Bajic, ... Oxidative medicine and cellular longevity 2019 (1), 5028181, 2019 | 150 | 2019 |
| Heart disease in diabetic patients MC Blendea, SI McFarlane, ER Isenovic, G Gick, JR Sowers Current Diabetes Reports 3 (3), 223-229, 2003 | 139 | 2003 |
| Link between oxidative stress and acute brain ischemia D Radak, I Resanovic, ER Isenovic Angiology 65 (8), 667-676, 2014 | 137 | 2014 |
| Thrombin and vascular inflammation M Popović, K Smiljanić, B Dobutović, T Syrovets, T Simmet, ER Isenović Molecular and cellular biochemistry 359, 301-313, 2012 | 134 | 2012 |
| Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome N Abate, H S Sallam, M Rizzo, D Nikolic, M Obradovic, P Bjelogrlic, ... Current pharmaceutical design 20 (31), 4961-4969, 2014 | 133 | 2014 |
| Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study M Rizzo, N Abate, M Chandalia, AA Rizvi, RV Giglio, D Nikolic, ... The journal of clinical endocrinology & metabolism 100 (2), 603-606, 2015 | 127 | 2015 |
| Human cytomegalovirus infection and atherothrombosis M Popović, K Smiljanić, B Dobutović, T Syrovets, T Simmet, ER Isenović Journal of Thrombosis and Thrombolysis 33, 160-172, 2012 | 109 | 2012 |
| Role of C‐reactive protein in diabetic inflammation J Stanimirovic, J Radovanovic, K Banjac, M Obradovic, M Essack, ... Mediators of inflammation 2022 (1), 3706508, 2022 | 103 | 2022 |
| Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with α-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism MS Bitar, AK Ayed, SM Abdel-Halim, ER Isenovic, F Al-Mulla Life Sciences 86 (23-24), 844-853, 2010 | 93 | 2010 |
| Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile E Stokić, A Kupusinac, D Tomić-Naglić, BK Zavišić, M Mitrović, ... Angiology 66 (3), 237-243, 2015 | 86 | 2015 |
| PCSK9 inhibition-a novel mechanism to treat lipid disorders? M Banach, M Rizzo, M Obradovic, G Montalto, J Rysz, D P. Mikhailidis, ... Current pharmaceutical design 19 (21), 3869-3877, 2013 | 79 | 2013 |
